PIK3CA and hepatocellular carcinoma: Patients with PI3K pathway alterations (red curve) exhibited a notable decline in survival probability compared to those without alterations (blue curve), suggesting that PI3K dysregulation may contribute to disease progression and worse prognosis in NHW HCC.